Showing posts with label infection prevention and control. Show all posts
Showing posts with label infection prevention and control. Show all posts

Sunday, September 21, 2014

Ebola virus, HCWs infections and personal protective equipment..

Co-authored by Dr Katherine Arden.

No one could offer anything but our deepest and most heartfelt thanks and a feeling of pride in the selfless, essential and humanitarian work being done by healthcare workers (HCWs), both local and international, in West Africa.

But they have paid a high price for this work, as they always do in emerging disease outbreaks.


WHO Ebola virus disease
numbers up to
14-Sept-2014
Of the >5,300 people reported as infected by the West African variant of Zaire ebolavirus (EBOV) to date, around 315 have been HCWs. Both numbers are very likely an underestimate. Half of the HCW cases have died. I don't know just how many HCWs there are in Guinea, Liberia and Sierra Leone who are dealing with the EBOV outbreak. I do know that these deaths are as horrible as each of the losses among non-HCWs, and are also worrying for those trying to recruit the many more HCWs needed to expand care of ill patients.


This week a commentary article on the Centre for Infectious Disease Research and Policy (CIDRAP) website delves into this issue by suggesting an improvement to HCW respiratory protection.[1]


Two quick things first:

  1. The World Health Organization (WHO) defines human transmission of Ebola virus as being by direct contact (between mucous membranes or a break in the skin and the blood and other body fluids of an infected individual via physical contact or by wet material being propelling onto mucous membranes or skin breaks) and by indirect contact via contaminated surfaces.[3,4]
  2. When dealing with patients, the WHO recommends wearing gloves, a disposable impermeable gown to cover exposed skin, a waterproof apron over any gown that is not impermeable or when undertaking strenuous activity, facial protection to prevent splashes to the nose, mouth and eyes including a medical mask + eye protection (visor or goggles) or a face shield and medical mask.[3]
The CIDRAP article's authors claimed a belief that there is scientific and epidemiologic evidence that Ebola virus has the potential to be transmitted via infectious particles. Unfortunately they don't make a convincing argument to support their belief-nor could they, since no data currently exist to for any claim that an Ebola virus is transmitted between humans by an airborne route. So we're left with a commentary based on those beliefs, and some speculation.

Some collaborators and I wrote about Ebola virus not being an airborne virus based on what we know and what's been done to answer this question before.[2] I'll first add that if it were an airborne virus, we would likely be seeing many, many more cases-"Compared to this Ebola outbreak, the H1N1 swine flu had already spread to an estimated 10,000 times as many people in its first 10 months" noted United Kingdom virologist Ben Neuman.[13] H1N1 being an influenza A virus; a real airborne virus. In our post, we noted that big wet droplets (part of an "aerosol"-a messy term that may not be well understood by the public...or some scientists...that includes big wet droplets and small rapidly drying droplets) can be propelled at a mucous membrane or fall to the ground to contaminate surfaces.


A schematic of the makeup of an "aerosol".
From [2]
Big wet propelled droplets can contain infectious Ebola virus and are included in the established risk messaging. Hence the need for droplet precautions.

We also know that from every human aerosol, after the heavy larger droplets fall to the ground or impact on a surface, the remaining lighter droplets very quickly dry to form droplet nuclei (these can be gelatinous, gooey, or water-free). It's these droplet nuclei that can linger for hours or more in the air. We know that droplet nuclei can be made to contain infectious Ebola virus under lab conditions[8] thus droplet nuclei produced by an infected human may contain Ebola virus. We can't say with certainty that they do or do not. However, as far as we have been able to tell, infection of humans and resultant disease from inhaling lingering droplet nuclei, has not occurred. And when an airborne route was investigated using infected and uninfected non-human primates housed nearby but without direct contact, no infection via an airborne route was found to have taken place.[9]


When putting one's faith in the belief that a different piece of PPE will prevent or significantly reduce HCW infections, one has to wonder if that will empower a false sense of security among HCWs in the field where the infections are happening. Most of the studies looking at aerosol of Ebola virus do so in temperature and humidity-controlled laboratories with lots of lab grown virus.


And relying on one added component raises a few questions for me:

  • Could the faith in this one extra precaution threaten the very important, meticulous care required when donning, using, and removing contaminated PPE-of any sort?
  • What role does a lack of the basics, like soap and clean water [10], play in HCW infections?
  • Could an additional extra safety measure really have a major effect on reducing the known risks involved with treating Ebola virus disease (EVD) patients, such as the long hours, tiredness, the constant and pervasive tension of imminent exposure, the oppressive heat, delirious and sometimes violent patients and the ease with which one can self-inoculate?[6]
  • Does the extra safety measure even have a role in reducing risk associated with HCWs who are unknowingly infected while not wearing PPE?[7]
How much do the things listed above, mostly unrelated to having a hi-tech battery-powered breathing apparatus on your hip, contribute to the tally of HCW infections?

Glaringly, the authors overlooked mentioning that early on, many HCWs may have had few or no masks at all and few other essential barriers such as those listed by WHO above, to protect against direct contact. They also did not mention the lack of HCW training in the use of any of that equipment if available, and did not highlight the lack of experience HCWs had dealing with EVD patients. These HCWs had (and may well still have) direct contact with very ill EVD cases, and got infected. What fraction of HCW infections resulted from absent or incomplete PPE and training versus the HCWs that they believe became ill while wearing full droplet precaution PPE?



Embedded image permalink
MSF designed suit of PPE.
Graphic tweeted by the
Washington Post.[5]
Others have also made note of the disparities between the imagery of a biosafety level 4 (BSL4) laboratory researcher working in a negatively pressurized, airlocked laboratory within a tethered, airtight suit (probably unnecessarily high precautions [13]) versus highly biocontained single patients being shipped home on dedicated planes (kept somewhat contamination-free using isolators) to rich nations for specialized support and treatment versus Médecins Sans Frontières (MSF) workers who use respirators (specialized face masks that fit more snugly and contain more layers to better filter what is breathed in) instead of surgical masks versus the WHO recommendations of standard precautions which include a surgical mask. Notably, the WHO recommendations vary according to the type of risk one is exposed too [see pg 96-7 96 of the 113 pg PDF at [3]).[10] There clearly is a range of thinking and messages here. But equally, there are a lot of different applications to cover, and no way for every need to be specifically catered for by one guideline. If everyone could agree on such a thing anyway.

I share the concern of many over the deaths of HCWs in West Africa. They may still be unnecessarily exposed to virus due to the lack of enough PPE. They may not have enough training to understand how easy it is to become infected. They may not be given the message that during an EVD outbreak as monstrous and different as this one, many heavily populated areas have been included for the first time resulting in very real risks of infection occurring outside the hospital setting, not just inside it. There are also real risks of infection in supposedly EVD-free hospital settings like maternity wards.[11] There are many, many non-airborne related risks for HCWs.


We freely admit that we are not trained in the use of PPE for treating Ebola patients; just for working with actual respiratory and blood borne viruses in PC2 & PC3 laboratory settings, respectively. Still, some may find this post irrelevant.
By all means stop and read that disclaimer on the right about this blog not providing medical advice. You come here of your own free will and this blog is not part of any Organization's reference list when they write PPE guidelines...because it's a blog.

But for what it's worth, I would follow the MSF lead if working in the battlefield of a 100+ bed treatment facility. In an ideal world with unlimited and readily available resources, a more roomy and breezy head covering that allows patients to see your face and which can be worn for longer periods would be useful. You can see an image, provided by 3M, of this battery-powered air-purifying respirator (PAPR) accompanying the CIDRAP post.


However....first and foremost, and well before we get to this level of hair-splitting based on speculation and belief and no evidence of an airborne virus-I'd be wanting to make sure there was a minimum level of disposable PPE actually available for use by every HCW and the appropriate education about how to use it and about all the risks for acquiring EBOV infection.

Reasons for HCW infections are many and varied. As much as we may believe or wish it were so, no single act or change will circumvent these risks nor these infections.


References..

Saturday, May 24, 2014

MERS-CoV among healthcare workers: no longer identified or the end of a hospital cluster?

Just looking at @maiamajumder's vast array of MERS-related charts on Twitter and had a thought.

She and I and others have been wondering for a while if perhaps the Kingdom of Saudi Arabia's (KSA) Ministry of Health (MOH) reporting has decided to simply no longer identify healthcare workers (HCWs) as such. That would not be the strangest thing to occur with these data, believe me (deaths that have been "previously reported" that actually haven't, people who were discharged from hospital who were previously not described as being hospitalised, and of course, some instances of HCWs in KSA being identified as MERS-CoV positive by their country of origin and not by the KSA MOH). Perhaps not identifying HCWs is a way of attempting to stop pointing to what was a huge problem in infection prevention and control just last month?

But perhaps that is not entirely what is happening. 

Perhaps there is another reason and there may be some precedent to support it; HCW numbers have in fact realistically decreased because they are no longer being infected as often. Why not? Perhaps because April's Jeddah hospital-based MERS-CoV outbreak is under control. Have a look at the chart below. Some things to note afterwards:


Click on image to enlarge
  1. HCW numbers have stopped accumulating so rapidly. That mirrors total MERS-CoV detections of course. See some recent posts on the now receding wave of April's MERS surge here and here.
  2. The precedent I mentioned? When the Al-Ahsa hospital-related outbreak stopped in May 2013, so did the number of HCW positives/week dropped away. 
  3. There have clearly been a bunch of other HCW peaks which may also have been related to hospital-clusters that were not so obviously publicised (I'll have a loo over this some time in the future). Those spikes of HCW infections have narrower bases and higher peaks than does the Jeddah outbreak, so perhaps that can be used as an indication of them being short-lived clusters that were better controlled than Jeddah. Not rocket science I guess and probably stating the obvious to the experts out there.
  4. Infections in HCWs serve, as we already know, as a kind of sentinel system for identifying a spike in overall cases since more severe disease shows its face in hospitals and most likely represents the presence of other cases out in the community. His statement is much more believable now that we ;can look back and know that milder signs and symptoms of disease, or none at all, do not infrequently follow MERS-CoV infection).
I hope that our original hypotheses - that the KSA MOH has quashed identifying HCWs - was wrong. Heading towards Hajj-2014, it would be best to be polishing the very tarnished reputation of of the KSA MOH on matters ;of communication, not further damaging it.


Saturday, December 28, 2013

What to watch for with human parechovirus (HPeV) infections...

With HPeV infections generally around during summer (see specific earlier story arising from cases in babies from New South Wales), it's well worth mirroring the advice form NSW health on what to look for. 

The full sources of this information can be visited at the pages listed below.

A brief agglomeration of the information...

HPeV (closely related to enteroviruses) has been detected in a number of neonates and young infants admitted to NSW hospitals during October and November 2013. Infants present very unwell with a rapid onset of acute sepsis-like (whole-body or systemic inflammation to a widespread infection) symptoms and can infect teh central nervous system. This is often followed by an erythematous, often confluent rash. Children under 3 months of age are the group most likely to develop severe disease, but most recover with supportive treatment.

Suspect HPeV infections in neonates (newborn) or young infants can present with a fever (>38.0°C) and:

  • Irritability and appearing to be in pain 
  • Tachypnoea
  • Maculopapular or erythematous rash 
  • Encephalitis
  • Diarrhoea or loose stools 
  • Myoclonic jerks
  • Tachycardia 
  • Hepatitis

How is it diagnosed?

Stool samples, nose and throat swabs, cerebrospinal fluid (CSF), or blood can be tested for HPeV at a specialist laboratory.

Initial Management and Treatment


Children presenting with a fever, sepsis-like signs &/or neurological signs, including irritability, should be assessed and treated for suspected sepsis using local protocols and discussed with an Emergency Consultant or Paediatrician.
There is no specific treatment for HPeV, treatment is supportive only.

How is HPeV disease prevented?


There is no vaccine to protect you from HPeV infection.

Good hygiene is the best protection: wash hands with soap and water after going to the toilet, before eating, after wiping noses, and after changing nappies or soiled clothing
Ensure the mouth and nose are covered when coughing and sneezing. Wipe the nose and mouth with tissues, dispose of used tissues and then wash your hands.

People who are unwell with colds, flu-like illness or gastro illness should stay away from small babies. 

If you are caring for a small baby and are unwell, wash your hands or use an alcohol-based hand rub before touching or feeding the baby.

Further reading...

Thursday, October 31, 2013

Infection prevention and control and MERS

Harriman, Brosseau and Triverdi have written to the Editor of the New England Journal of Medicine (NEJM) to express their concerns over the lack of apparent preventative measures undertaken during the Al-Ahsa Middle East respiratory syndrome (MERS) coronavirus outbreak communicated by Assiri et al (previously reviewed here).

The new letter indicates that with so little known about MERS-CoV transmission route(s), a safer bet would have been to protect healthcare workers as much as possible. They suggest use of  respirators rather than surgical masks (see Mike Coston's reviews of the differences here, here, here, here and here...likes his masks does Mike). 

Possibly eye protection as well given the transmission unknowns. 

I've previously listed these and other precautions for managing patients with endemic or with less well-defined respiratory pathogens. Worth a reminder read.

The authors highlight it would be prudent, in a well-resourced country like the Kingdom of Saudi Arabia, to roll out as many extra personal protective safeguards for the front-line healthcare workers as possible; at least while the slow hunt to understand how the virus is acquired and transmitted seeks some answers.

The reply to this letter by Memish, Al-Tawfiq and Assiri did not specifically agree with its specifics or address enhanced care for HCWs, instead restating what was done to respond. The key comment summing up the use of respirators indicates a reactive rather than proactive approach to HCW care in trying to prevent a case from spreading their laboratory confirmed infection. 

...putting surgical masks on all patients undergoing hemodialysis and particulate respirators (N95 masks) on any patient with confirmed MERS-CoV who was undergoing an aerosol-generating procedure...

As we've seen over and over again during this outbreak and others, by the time a laboratory confirmation is available, it is far too late to halt early transmission events

When those events occur in a hospital environment it's not just the relatively (to the MERS-CoV case averages) younger and more healthy HCWs that are at risk of infection and disease. MERS-CoV and other respiratory viruses are at their most lethal among the elderly with comorbidities. Delays in lab testing, in waiting for something to happen or in following other's guidelines to the letter rather than modifying or creating new ones based on front-line experiences, can have severe consequences.

I take the message from this letter as: Be proactive not reactive.

Thursday, October 17, 2013

Middle East coronavirus infection control and personal protective equipment...

...are not at all part of the thinking judging by the imagery in this story on alRiyadh.

For a virus that kills 2 in 5 symptomatic people and for which animal hosts or intermediate hosts remain to be excluded or confirmed, there is an alarming and completely irresponsible level of safety being employed by those workers.

Thanks to FluTrackers for bringing it to my attention.

Thursday, August 8, 2013

Infection Prevention and Control measures for MERS..mostly as per other ARIs

Thanks to Mike Coston for help and tips.

Cases are few and details are incomplete but the authors of an article in the recent MERS-centric issue of the EMRO Journal, recommend following the basic protocols you would to suppress spread of any virus capable of causing an acute respiratory infection (ARI) with a leaning towards those that worked well to interrupt hospital-based spread of severe acute respiratory syndrome (SARS) coronavirus.

Some key points from the paper, of highest relevance to our current knowledge of the  MERS-CoV are  listed include (not in specific order or priority):

  1. Identify patients with ARIs and prevent them from transmisttign the agent to helathcare worklers and patients
  2. Droplet and contact precautions for people with ARIs
  3. Separate ARI patients by ≥1m from other patients and from HCWs
  4. Use personal protective equipment (PPE) including eye protection, gloves, long-sleeved gowns and surgical mask/procedure mask/particulate respirator if aerosol-generating procedures are to be performed (tracheal intubation alone or with cardiopulmonary resuscitation or bronchoscopy being notable risks)
Mike Coston's description of the mask debate is very helpful for #4 above.

If a particular infectious diagnosis can be made, then patients with that diagnosis, say MERS-CoV,  can be cohorted - co-located to minimize spread to uninfected patients and maximise specialised care and efficient use of available resources.

Specifically, the article includes a list of SARS-like IPC precautions listed include which may be useful for known MERS-CoV infections. Many of these apply to ARIs due to endemic respiratory viruses and novel influenza viruses in general though:

  • Good hand hygiene
  • Use of PPE (gloves, gown, eye protection and medical masks for HCWs, caregivers and the patient if oputside their room
  • Particulate respirator for aerosol generating procedures
  • Separate, adequately ventilated room
While the above is written for dealing with infection in a healthcare setting, the WHO have also just released a rapid advice document for those caring for mildly ill MERS-CoV-infected people without underlying conditions, or those recently discharged from hospital. A mashup of 16 distinct points (read the document to see the full language and exceptions) home IPC are:

  • Limit contact with the ill person - maintain distance (perhaps limit exposure time?). 
  • Do not allow people at increased risk to care for the ill person
  • Hand hygiene and respiratory hygiene are important as are appropriate (soap and water, bl;each as recommended) cleaning of all surfaces in contact with the person or their secretions - kitchen, bathroom, toilet, bedframe, bedside tables, furniture etc
  • Discard contaminated tissues, masks etc
  • Clean clothes
  • Do not share eating utensils food or drionk, towels or bed linen
  • Caregiver to wear a mask - discard after use and do not handle while in use
  • Ventilate shared spaces

Close medical supervision is recommended for symptomatic or probable MERS cases and their contacts.

The WHO home care advice also notes lack of evidence for transmission of MERS (the disease) from asymptomatic, pre-symptomatic or early-symptomatic people. Thus quarantine or isolation of asymptomatic cases is currently unnecessary but possibly exposed people should monitor their health for 14-days.


Key documents and official websites to be familiar with: